Ondrey Aaron 4
4 · Mirati Therapeutics, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Ondrey Aaron
Interim CFO
Transactions
- Award
Common Stock
2023-12-29$58.75/sh+17,021$999,984→ 39,461 total
Footnotes (1)
- [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.